Harshad Kulkarni

9.9k total citations · 3 hit papers
137 papers, 4.4k citations indexed

About

Harshad Kulkarni is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, Harshad Kulkarni has authored 137 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Radiology, Nuclear Medicine and Imaging, 58 papers in Oncology and 55 papers in Epidemiology. Recurrent topics in Harshad Kulkarni's work include Radiopharmaceutical Chemistry and Applications (64 papers), Neuroendocrine Tumor Research Advances (55 papers) and Lung Cancer Research Studies (36 papers). Harshad Kulkarni is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (64 papers), Neuroendocrine Tumor Research Advances (55 papers) and Lung Cancer Research Studies (36 papers). Harshad Kulkarni collaborates with scholars based in Germany, United States and India. Harshad Kulkarni's co-authors include Richard P. Baum, Aviral Singh, Christiane Schuchardt, Ingo Klette, Jingjing Zhang, Dirk Müeller, Karin Niepsch, Margret Schottelius, Hans‐Jürgen Wester and Natalie Mladenov and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Harshad Kulkarni

132 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

⁶⁸Ga- and ¹⁷⁷Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies

2015 419 citations Richard P. Baum, Harshad Kulkarni et al. Journal of Nuclear Medicine profile →
¹⁷⁷Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

2016 397 citations Richard P. Baum, Harshad Kulkarni et al. Journal of Nuclear Medicine profile →
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

2021 210 citations Richard P. Baum, Christiane Schuchardt et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harshad Kulkarni Germany	36	2.4k	1.9k	1.7k	1.3k	690	137	4.4k
Robert Clough United States	39	1.1k 0.4×	829 0.4×	1.6k 0.9×	240 0.2×	155 0.2×	128	4.5k
Suzanne E. Lapi United States	32	1.8k 0.7×	756 0.4×	645 0.4×	165 0.1×	65 0.1×	194	3.2k
Lydia B. Zablotska United States	29	1.6k 0.7×	333 0.2×	483 0.3×	170 0.1×	33 0.0×	102	3.0k
Jeanne M. Link United States	41	2.8k 1.2×	1.0k 0.5×	739 0.4×	147 0.1×	136 0.2×	73	4.7k
Shuhang Wang China	37	248 0.1×	1.8k 1.0×	1.3k 0.8×	249 0.2×	28 0.0×	216	4.4k
Brian J. Davis United States	41	1.3k 0.5×	491 0.3×	4.5k 2.6×	142 0.1×	59 0.1×	229	6.6k
Olca Baştürk United States	50	248 0.1×	6.1k 3.3×	1.4k 0.9×	3.1k 2.4×	1.3k 1.9×	183	8.3k
Zhi Yang China	32	1.4k 0.6×	1.3k 0.7×	710 0.4×	330 0.3×	151 0.2×	244	3.5k
Michael K. Schultz United States	34	955 0.4×	348 0.2×	353 0.2×	281 0.2×	95 0.1×	151	3.4k
Alina V. Brenner United States	36	1.6k 0.7×	815 0.4×	742 0.4×	299 0.2×	84 0.1×	111	4.2k

Countries citing papers authored by Harshad Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Harshad Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harshad Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harshad Kulkarni more than expected).

Fields of papers citing papers by Harshad Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harshad Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harshad Kulkarni. The network helps show where Harshad Kulkarni may publish in the future.

Co-authorship network of co-authors of Harshad Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Harshad Kulkarni. A scholar is included among the top collaborators of Harshad Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harshad Kulkarni. Harshad Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Han, et al.. (2025). Diatom-Based Photobiological Treatment of Reverse Osmosis Concentrate: Optimization of Light and Temperature and Biomass Analysis. SHILAP Revista de lepidopterología. 5(1). 3–3.

Bodei, Lisa, Marta Cremonesi, Mahila Ferrari, et al.. (2025). Dosimetry of [¹⁷⁷Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial. Journal of Nuclear Medicine. 66(3). 449–456. 6 indexed citations

Kulkarni, Harshad, et al.. (2025). Exploration of multifaceted domain of advanced membrane separation processes for wastewater treatment and desalination – A review. Desalination. 614. 119133–119133. 4 indexed citations

Kulkarni, Harshad, et al.. (2024). Impact of surficial lithology on arsenic mobility in riverbanks of tidally fluctuating rivers: The Hooghly River, West Bengal, India. Journal of Hydrology. 641. 131773–131773. 1 indexed citations

Kulkarni, Harshad, et al.. (2024). Diverse sedimentary organic matter within the river-aquifer interface drives arsenic mobility along the Meghna River Corridor in Bangladesh. Applied Geochemistry. 161. 105883–105883. 6 indexed citations

Kulkarni, Harshad, Kevin A. Maupin, Tina Brennan, et al.. (2024). First-in-Human Total-Body PET/CT Imaging Using⁸⁹Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma. Journal of Nuclear Medicine. 65(11). 1815–1815.

Olivares, Rubén, et al.. (2024). Hydrogeochemical assessment of groundwater in transboundary aquifers along the US-Mexico border and drinking water quality implications for Texas colonias. Groundwater for Sustainable Development. 27. 101377–101377. 1 indexed citations

Kluge, Andreas, et al.. (2024). Immune Response to Molecular Radiotherapy with ¹⁷⁷ Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome. Cancer Biotherapy and Radiopharmaceuticals. 39(7). 541–550. 1 indexed citations

Kulkarni, Harshad, et al.. (2023). Mineralogical Associations of Sedimentary Arsenic within a Contaminated Aquifer Determined through Thermal Treatment and Spectroscopy. Minerals. 13(7). 889–889. 6 indexed citations

10.

Baum, Richard P., Aviral Singh, Harshad Kulkarni, et al.. (2021). First-in-Humans Application of ¹⁶¹Tb: A Feasibility Study Using ¹⁶¹Tb-DOTATOC. Journal of Nuclear Medicine. 62(10). 1391–1397. 59 indexed citations

11.

Barber, Thomas W., Aviral Singh, Harshad Kulkarni, et al.. (2019). Clinical Outcomes of ¹⁷⁷Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy. Journal of Nuclear Medicine. 60(7). 955–962. 104 indexed citations

12.

Zhang, Jingjing, Harshad Kulkarni, & Richard P. Baum. (2019). Ectopic Corticotropin-Releasing Hormone–Secreting Pancreatic Neuroendocrine Tumor. Clinical Nuclear Medicine. 45(2). e125–e127. 2 indexed citations

13.

Zhang, Jingjing, Harshad Kulkarni, Aviral Singh, & Richard P. Baum. (2019). Prostate-Specific Membrane Antigen Accumulation in Lower Extremity Lymphedema. Clinical Nuclear Medicine. 44(6). 501–503. 1 indexed citations

14.

Zhu, Wenjia, Jingjing Zhang, Aviral Singh, Harshad Kulkarni, & Richard P. Baum. (2019). Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide Therapy. Clinical Nuclear Medicine. 44(12). 989–990. 8 indexed citations

15.

Kulkarni, Harshad, Natalie Mladenov, & Saugata Datta. (2018). Effects of acidification on the optical properties of dissolved organic matter from high and low arsenic groundwater and surface water. The Science of The Total Environment. 653. 1326–1332. 25 indexed citations

16.

Ronot, Maxime, Ashley Kieran Clift, Richard P. Baum, et al.. (2017). Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases. Neuroendocrinology. 106(1). 74–88. 42 indexed citations

17.

Singh, Aviral, Nicholas P. van der Meulen, Cristina Müller, et al.. (2017). First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced ⁴⁴ Sc-DOTATOC: A Proof-of-Concept Study. Cancer Biotherapy and Radiopharmaceuticals. 32(4). 124–132. 52 indexed citations

18.

Baum, Richard P., Harshad Kulkarni, Dirk Müller, et al.. (2015). First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with ⁶⁸ Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for α _v β ₃ Integrin Receptor Targeting. Cancer Biotherapy and Radiopharmaceuticals. 30(4). 152–159. 19 indexed citations

19.

Baum, Richard P., et al.. (2012). Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms. Seminars in Nuclear Medicine. 42(3). 190–207. 90 indexed citations

20.

Mahoui, Malika, et al.. (2006). BioFacets: Integrating Biological Databases using Facetted Classification.. 205–210. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact